Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of Datadog (NasdaqGS:DDOG) with a Overweight ...

Cantor Fitzgerald began coverage on Oracle Corporation (NYSE:ORCL) stock, giving the tech giant an Overweight rating and ...

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price ...

Cantor Fitzgerald initiated coverage of Datadog (DDOG) with an Overweight rating and $180 price target Stay Ahead of the Market:Discover ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald from ...

Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $15.26 which represents a slight increase of $0.44 or 2.97% from the prior close of $14.82. The stock opened at $15.21 ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most substantial contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90%.